Kingdom Financial Group’s Quest Diagnostics DGX Stock Holding History

Kingdom Financial Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$123	Hold	1	–	–	﹤0.01%	801
2025 Q4	$109	Buy	+1	New	+$182	﹤0.01%	695

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Kingdom Financial Group's DGX Position: Q1 2026 in Review

Kingdom Financial Group held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1 share worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Kingdom Financial Group first reported a position in DGX in Q4 2025 and has held it in 2 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Kingdom Financial Group held 1 share of Quest Diagnostics worth $123 as of Q1 2026.
Kingdom Financial Group left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up ﹤0.01% of Kingdom Financial Group's portfolio in Q1 2026, its #801 holding.
Kingdom Financial Group first reported a position in Quest Diagnostics in Q4 2025 and has held it in 2 quarters since.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Kingdom Financial Group's 13F filing for Q1 2026, filed 13 May 2026.